Copyright
©The Author(s) 2022.
World J Hepatol. Aug 27, 2022; 14(8): 1643-1651
Published online Aug 27, 2022. doi: 10.4254/wjh.v14.i8.1643
Published online Aug 27, 2022. doi: 10.4254/wjh.v14.i8.1643
Table 2 Variables for the definition of sarcopenia by the European Working Group of Sarcopenia in Older People, 2010 and 2018
| Variable | EWGSOP1 | EWGSOP2 |
| Muscle mass, n (%) | ||
| Adequate | 54 (94.7) | 57 (100) |
| Low | 3 (5.3) | 0 (0.0) |
| Muscle strength, n (%) | ||
| Adequate | 27 (47.4) | 41 (71.9) |
| Low | 30 (52.6) | 16 (28.1) |
| Physical performance, n (%) | ||
| Adequate | 48 (84.2) | 41 (71.9) |
| Low | 9 (15.8) | 16 (28.1) |
- Citation: Almeida NS, Rocha R, de Souza CA, da Cruz ACS, Ribeiro BDR, Vieira LV, Daltro C, Silva R, Sarno M, Cotrim HP. Prevalence of sarcopenia using different methods in patients with non-alcoholic fatty liver disease. World J Hepatol 2022; 14(8): 1643-1651
- URL: https://www.wjgnet.com/1948-5182/full/v14/i8/1643.htm
- DOI: https://dx.doi.org/10.4254/wjh.v14.i8.1643